Pulmonary Hypertension Clinical Trial
Official title:
Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension
The aim of the present study is to identify changes in the cardiovascular system in patients
with pulmonary hypertension (PH) by magnetic resonance imaging (MRI). MRI is accepted as
golden standard method for the evaluation of left and right ventricular morphology and
function.
All patients who showed elevated pulmonary pressure in the right heart catheter
investigation are assigned to MRI. Parameters derived from MRI are included in the clinical
and therapeutic decisions. Well established as well as new MRI parameters are evaluated and
compared to the results of right heart catheter. Further age-matched controls without known
cardiac or pulmonary disease are investigated by native MRI.
Patients with suspected, latent and manifest PH and controls are investigated by MRI
according to the following protocol in breathhold or free breathing (depending on the
patients' breath-hold abilities). In case of elevated Creatinin values, no contrast agent is
applied.
- Planning of cardiac views: Planning of 2-chamber view, short axes view and 4-chamber
view.
- Morphological overview: Transversal and coronal Haste images
- Left and right heart functional and valve evaluation: Cine 2-chamber imaging,
Multi-slice cine 4-chamber imaging, Cine Left and Right ventricular outflow tract
imaging and Multi-slice cine short axes imaging covering the left and right ventricle
for evaluation of EDV, ESV, SV, EF, CO and muscle mass.
- Phase Contrast Imaging: Flow measurements in the aorta, the pulmonary artery and the
heart.
- Perfusion measurement.
- Late enhancement measurement: Multi-slice short axes view, multi-slice 2-chamber view
and multi-slice 4-chamber view.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
| Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
| Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
| Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
| Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
| Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
| Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
| Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
| Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
| Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
| Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|
||
| Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 | |
| Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
| Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A |